Your browser doesn't support javascript.
loading
Epilepsy and Anti-Seizure Medications: Secret Agents for Endocrine Disruption.
Sazgar, Mona; Mnatsakanyan, Lilit; Pack, Alison M; Harden, Cynthia L.
Afiliación
  • Sazgar M; Department of Neurology, University of California, Irvine CA, USA.
  • Mnatsakanyan L; Department of Neurology, University of California, Irvine CA, USA.
  • Pack AM; Department of Neurology, Columbia University, New York, NY, USA.
  • Harden CL; Xenon Pharmaceuticals Inc, Burnaby, British Columbia, Canada.
Epilepsy Curr ; 24(2): 79-83, 2024.
Article en En | MEDLINE | ID: mdl-39280049
ABSTRACT
There is a reciprocal relationship between epilepsy and reproductive endocrine disorders. Seizures and anti-seizure medications (ASMs) can contribute to reproductive and endocrine dysfunction and reproductive dysfunction may exacerbate seizures. Epilepsy via neuroendocrine mechanisms affects the hypothalamic-pituitary-ovarian (HPO) axis, disrupting the regulation of gonadotropin secretion, and resulting in dystrophic effects on the ovaries and early menopause. Anti-seizure medications have endocrine-related side effects on sexual function and bone health. Long-term use of ASMs may result in menstrual irregularities, sexual dysfunction, anovulatory cycles, polycystic ovaries, and reduced fertility. Some ASMs also interfere with bone metabolism. Epilepsy patients treated with ASMs are at risk for bone loss and fractures. This article explores the endocrine and hormonal effects of seizures and ASMs.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Epilepsy Curr Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Epilepsy Curr Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos